KTTA

Pasithea Therapeutics Corp. (KTTA)

About Pasithea Therapeutics Corp. (KTTA)

Pasithea Therapeutics Corp. is a biotechnology company focuses on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Steinman Lawrence J in May, 2020 and is headquartered in Miami Beach, FL.

Details

Daily high
$2.10
Daily low
$1.93
Price at open
$2.02
52 Week High
$9.25
52 Week Low
$1.93
Market cap
3.5M
Dividend yield
0.00%
Volume
747,052
Avg. volume
3.5M
P/E ratio
-.18

Pasithea Therapeutics Corp. News

Details

Daily high
$2.10
Daily low
$1.93
Price at open
$2.02
52 Week High
$9.25
52 Week Low
$1.93
Market cap
3.5M
Dividend yield
0.00%
Volume
747,052
Avg. volume
3.5M
P/E ratio
-.18